EMERGING MARKET COUNTRIES MOVING TOWARD MORE LOCAL VACCINE MANUFACTURE
March 18th, 2014
ALTHOUGH two-thirds of vaccine research and development (R&D) globally is carried out by European firms, manufacturers in China, India and Brazil are becoming increasingly muscular and “moving from dependency to self-sufficiency” experts at a two-day conference in Brussels on vaccine research heard last week.Dr Suresh Jadhav, executive director of Serum Institute of India Ltd, said there is a declining interest by major international pharma companies’ in the Expanded Programme on Immunisation (EPI) funded by the World Bank, leaving a gap developing ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.